Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]

Kristel M. Crommentuyn; Alwin D. Huitema; Kees Brinkman; Marchina E. van der Ende; Frank de Wolf; Jos H. Beijnen

Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]

Kristel M. Crommentuyn
, Alwin D. Huitema
, Kees Brinkman
, Marchina E. van der Ende
, Frank de Wolf
, Jos H. Beijnen

Slotervaart Hospital
Erasmus MC
HIV Monitoring Foundation, Amsterdam, Netherlands
Imperial College London
Utrecht University

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	249-250
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	39
Issue number	2
Publication status	Published - 1 Jun 2005

Cite this

@article{db10db183e6544e6a7e0bdb7e08882ca,

title = "Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]",

author = "Crommentuyn, \{Kristel M.\} and Huitema, \{Alwin D.\} and Kees Brinkman and \{van der Ende\}, \{Marchina E.\} and \{de Wolf\}, Frank and Beijnen, \{Jos H.\}",

year = "2005",

month = jun,

day = "1",

language = "English",

volume = "39",

pages = "249--250",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

number = "2",

}

Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]. / Crommentuyn, Kristel M.; Huitema, Alwin D.; Brinkman, Kees et al.
In: Journal of Acquired Immune Deficiency Syndromes, Vol. 39, No. 2, 01.06.2005, p. 249-250.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]

AU - Crommentuyn, Kristel M.

AU - Huitema, Alwin D.

AU - Brinkman, Kees

AU - van der Ende, Marchina E.

AU - de Wolf, Frank

AU - Beijnen, Jos H.

PY - 2005/6/1

Y1 - 2005/6/1

UR - https://www.scopus.com/pages/publications/19644362031

UR - https://www.ncbi.nlm.nih.gov/pubmed/15905743

M3 - Comment/Letter to the editor

C2 - 15905743

SN - 1525-4135

VL - 39

SP - 249

EP - 250

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 2

ER -

Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study [1]

Other files and links

Cite this